Cited by 8Renal Diseases and GlomerulopathiesLipid metabolism and disordersChronic Kidney Disease and Diabetes

A novel apolipoprotein E mutation (p.Arg150Cys) in a Chinese patient with lipoprotein glomerulopathy

Open access
Ku, Ming, Tao, Cai, Zhou, An-An, Cheng, Yuan, Wan, Qi-Jun·2019·Chinese Medical Journal

Abstract

To the Editor: Lipoprotein glomerulopathy (LPG) is an uncommon inherited renal disease characterized by lipoprotein thrombi in the markedly dilated capillary lumina of affected glomeruli, high plasma concentrations of apolipoprotein E (apoE), and proteinuria.[1] It mainly affects people of Japanese and Chinese origin, and approximately 117 cases have been reported to date.[2,3] Several genetic studies have demonstrated that APOE gene mutations may lead to the development of LPG;[4-6] however, conflicting published evidence has found that some patients with APOE variants were unaffected.[7] Thus, further studies are needed to examine the role of APOE mutations in the pathogenesis of LPG. This study investigated a novel point mutation in the APOE gene in a family with one LPG patient and an asymptomatic carrier of the same APOE variant. This study was conducted in accordance with the declaration of Helsinki and was approved by the Ethics Committee of Shenzhen University. Written informed consent was obtained from all participants. A 21-year-old Chinese woman was in good health until December 2016, when during a 3-month-antenatal examination, it was determined that she had moderate proteinuria. Throughout her pregnancy, she had moderate to severe proteinuria (up to 5.2 g/day). Four months after giving birth to a healthy baby girl, she was admitted to the hospital. She had no known family history of renal disease or lipidosis. The patient was 162 cm tall and weighed 55 kg. Her blood pressure was 115/77 mmHg. She did not have pedal edema. Her urinary protein excretion was 4.0 g/day, her glomerular filtration rate was 145 mL/min, and her urine sediment contained blood cells (5–8 red blood cells/high-power field). Twenty-four-hour urine protein was 2.4 g. Other laboratory examinations revealed white blood cell count: 5.08 × 109/L, hemoglobin: 119 g/L, platelet count: 146 × 109/L, albumin: 38 g/L, blood urea nitrogen: 4.2 mmol/L, serum creatinine: 45.8 μmol/L, uric acid: 525.6 μmol/L, total cholesterol (TC): 8.53 mmol/L, low-density lipoprotein cholesterol (LDL-C): 6.44 mmol/L, high-density lipoprotein cholesterol: 1.34 mmol/L, triglycerides (TG): 1.56 mmol/L, and fasting blood glucose: 4.46 mmol/L. Hepatitis B surface antigen, anti-hepatitis C antibody, and antinuclear antibody tests were all negative. Complement levels were normal. An abdominal ultrasound showed that her renal shape and size were normal, but marked splenomegaly was observed. A percutaneous renal biopsy was performed for definitive diagnosis. By light microscopy, a total of 21 glomeruli were evaluated, 2 of which showed global sclerosis. Glomerular volume was slightly increased and was distorted by markedly dilated diffuse capillaries containing pale-staining thrombi in a layered structure, and mesangial cells and stroma showed mild to moderate proliferation. A few of the glomeruli had small synechiae between the glomerular capillaries and Bowman capsules [Figure 1A]. Staining with oil red O showed a number of lipid droplets in the glomerular capillary lumina [Figure 1B]. Foam cells were not present in either the glomeruli or the tubulointerstitium. There was interstitial edema with focal inflammatory cellular infiltration, mild and limited interstitial fibrosis, and tubular atrophy. Routine fluorescent microscopy showed trace to 1+ linear deposits of immunoglobulin M (not shown). Other immunoglobulins, C3, C4, and C1q were not detected. Strong, segmental staining for both apoE [Figure 1D] and apoB (not shown) was observed in the capillary lumina. One glomerulus was examined by electron microscopy. Almost all of the dilated capillary lumina were occluded by numerous lipid granules and lamellate vacuoles [Figure 1C].Figure 1: Glomerular findings from renal biopsy specimens in a 21-year-old Chinese LPG patient (II-1, proband). Light microscopy showed that the capillary lumina were dilated by amorphous lipoprotein thrombi (A; periodic Schiff-methenamine staining, × 400), and massive pale-stained deposits were observed in the capillary lumen (B; Oil-red-O staining, × 400). Electron micrograph showed Lamellate thrombi occupy the capillary lumen (C, × 4000). Segmental immunofluorescent stainings of apoE were present in the glomeruli (D, × 400). (E) Nucleotide sequence of a segment of exon 4 in the APOE gene for both alleles of the proband (patient II-1). The lower panel shows the allele containing a nucleotide C to T point mutation at nucleotide 208 in codon 150 of the gene. (F) Family tree of patients with LPG. LPG: Lipoprotein glomerulopathy; apoE: apolipoprotein E.In this study, exon 4 of the APOE gene was analyzed in 4 separate individuals by DNA sequencing. Genomic DNA was extracted from blood using the DNA Blood Magen Kit (Magen, Guangzhou, China) and 1 mL of the extraction was used as a template for PCR amplification. Exon 4 of the APOE gene was amplified using PCR 2xTaq Master Mix (Vazyme, Nanjing, China). The primers for exon 4 were as follows:

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/cm9.0000000000000050

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 7

  1. [2]Saito T Matsunaga A Oikawa S Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases. Am J Kidney Dis 2006; 47: 199– 211. doi: 10.1053/j.ajkd.2005.10.017. 16431249 · DOI · Paper page
  2. [4]Hu Z Huang S Wu Y Liu Y Liu X Su D Hereditary features, treatment, and prognosis of the lipoprotein glomerulopathy in patients with the APOE Kyoto mutation. Kidney Int 2014; 85: 416– 424. doi: 10.1038/ki.2013.335. 24025644 · DOI · Paper page
  3. [5]Hagiwara M Yamagata K Matsunaga T Arakawa Y Usui J Shimizu Y A novel apolipoprotein E mutation, ApoE Tsukuba (Arg 114 Cys), in lipoprotein glomerulopathy. Nephrol Dial Transplant 2008; 23: 381– 384. doi: 10.1093/ndt/gfm735. 17967799 · DOI · Paper page
  4. [6]Kinomura M Sugiyama H Saito T Matsunaga A Sada KE Kanzaki M A novel variant apolipoprotein E Okayama in a patient with lipoprotein glomerulopathy. Nephrol Dial Transplant 2008; 23: 751– 756. doi: 10.1093/ndt/gfm675. 18045818 · DOI · Paper page
  5. [7]Chen S Liu ZH Zheng JM Zhang X Li LS A complete genomic analysis of the apolipoprotein E gene in Chinese patients with lipoprotein glomerulopathy. J Nephrol 2007; 20: 568– 575. PMID: 17918142. 17918142
  6. [8]Luo B Huang F Liu Q Li X Chen W Zhou SF Identification of apolipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy. Am J Nephrol 2008; 28: 347– 353. doi: 10.1159/000111828. 18046082 PMC2785906 · DOI · Paper page
  7. [9]Tudorache IF Trusca VG Gafencu AV Apolipoprotein E - A multifunctional protein with implications in various pathologies as a result of its structural features. Comput Struct Biotechnol J 2017; 15: 359– 365. doi: 10.1016/j.csbj.2017.05.003. 28660014 PMC5476973 · DOI · Paper page

Cited by

Sorted by citations

Authors
Ku, M., Tao, C., Zhou, A.-A., Cheng, Y., & Wan, Q.-J.
Affiliations
Shenzhen University (CN)
Venue
Chinese Medical Journal
Published
2019-01-20
Volume
132
Issue
2
Pages
237-239
ISSN
0366-6999 (ISSN-L)
OpenAlex
W2909849386
Cited by
8
References
2
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2022: 2 · 2021: 2 · 2019: 1
FWCI
0.96
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Chinese Medical Journal (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Health and Family Planning Commission of Shenzhen Municipality
Topics
  • Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Keywords
lipoprotein glomerulopathy, apolipoprotein E, novel point mutation, proteinuria, familial inheritance, Chinese patients, genetic diagnosis, pathogenesis, hyperlipidemia, hyperuricemia, hypertriglyceridemia, hypercholesterolemia
MeSH terms
Adult, Apolipoproteins E, Exons, Female, Humans, Kidney Diseases, Mutation, Asian People, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review